Proton Therapy for Chordomas and/or Chondrosarcomas

A Clinical Outcomes Protocol of Proton Beam Radiation Therapy for Chordomas and/or Chondrosarcomas of the Base of Skull and/or Spine

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00797602

Acronym

CH01

Enrollment

189

Registered

2008-11-25

Start date

2007-01-31

Completion date

2015-12-31

Last updated

2017-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chondrosarcomas, Chordomas

Keywords

Chordomas, Chondrosarcomas, Cancer, Outcomes, Proton radiation

Brief summary

The purpose of this study is to collect information from medical records to see what effects proton beam radiation has on cancer and analyze possible side effects.

Detailed description

Data collection will be obtained from the patient's medical records including initial evaluation, pathology report, dosimetry information, radiotherapy completion records and follow-up.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Histologically proven chordoma or chondrosarcoma. * Sites: base of skull and/or spine. * Age 18 years or older.

Exclusion criteria

* Previous radiation to the head and neck or brain. * Evidence of metastatic disease.

Design outcomes

Primary

Measure	Time frame
Collect and analyze outcome data on tumor control.	When each patient has been followed for a minimum of 12 month and then again after 24 months to a maximum of 10 years.

Secondary

Measure	Time frame	Description
Collect and analyze data on normal tissue morbidity.	When each patient has been followed for a minimum of 12 months and then again after 24 months to a maximum of 10 years.	Specifically analyzing pituitary, visual and hearing function.

Countries

United States

Outcome results